FilingReader Intelligence
Mayinglong adopts new accounting policies, reinforcing financial integrity
April 2, 2025 at 05:19 PM UTC•By FilingReader AI
Mayinglong Pharmaceutical Group [SSE:600993] has announced changes to its accounting policies effective throughout 2024, as indicated in a filing released April 3, 2025. These adjustments, aligned with regulatory updates from the Ministry of Finance, aim to provide a more accurate and transparent representation of the company's financial status.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
Mayinglong's announcement on the profit distribution plan for 2024April 2, 2025 at 12:23 PM UTC
Mayinglong 2024 Annual ReportApril 2, 2025 at 12:23 PM UTC
Mayinglong 2024 Annual Audit ReportApril 2, 2025 at 12:23 PM UTC
Mayinglong 2024 Annual Report SummaryApril 2, 2025 at 12:23 PM UTC
Special audit report on the summary table of Mayinglong's non-operating capital occupation and other related capital transactions in 2024April 2, 2025 at 12:23 PM UTC
Mayinglong's announcement on providing loan guarantee quota for its subsidiariesApril 2, 2025 at 12:23 PM UTC
SSE:600993•Shanghai Stock Exchange
News Alerts
Get instant email alerts when Mayinglong Pharmaceutical Group publishes news
Free account required • Unsubscribe anytime